NRXPNRX Pharmaceuticals, Inc.

Nasdaq nrxpharma.com


$ 3.51 $ 0.40 (12.74 %)    

Friday, 26-Apr-2024 15:59:03 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 3.54
$ 3.24
$ 3.51 x 200
$ 3.55 x 200
$ 3.24 - $ 3.64
$ 2.21 - $ 54.00
280,114
na
3.39M
$ 0.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 08-14-2023 06-30-2023 10-Q
3 05-15-2023 03-31-2023 10-Q
4 03-31-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-15-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-31-2022 12-31-2021 10-K
9 11-15-2021 09-30-2021 10-Q
10 08-16-2021 06-30-2021 10-Q
11 05-21-2021 03-31-2021 10-Q
12 04-01-2021 12-31-2020 10-K
13 11-16-2020 09-30-2020 10-Q
14 08-14-2020 06-30-2020 10-Q
15 05-15-2020 03-31-2020 10-Q
16 03-30-2020 12-31-2019 10-K
17 11-14-2019 09-30-2019 10-Q
18 08-14-2019 06-30-2019 10-Q
19 05-15-2019 03-31-2019 10-Q
20 03-15-2019 12-31-2018 10-K
21 11-08-2018 09-30-2018 10-Q
22 08-08-2018 06-30-2018 10-Q
23 05-15-2018 03-31-2018 10-Q
24 03-23-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 dow-surges-over-100-points-dr-horton-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market...

 nrx-pharmaceuticals-receives-notice-from-nasdaq-that-the-company-has-demonstrated-compliance-with-the-bid-price-requirement

The Nasdaq Panel has determined to continue the listing of the Company's securities on The Nasdaq Stock Market and is closi...

 nrx-pharmaceuticals-inc-announces-pricing-of-2m-underwritten-public-offering-of-common-stock-at-a-public-offering-price-of-330-per-share

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmace...

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 nrx-pharmaceuticals-intends-to-offer-to-sell-shares-of-its-common-stock-in-public-offering-no-terms-disclosed

NRx Pharmaceuticals intends to use the net proceeds from the offering for working capital and general corporate purposes, inclu...

 nrx-pharmaceuticals-announces-development-of-new-proprietary-formulation-of-htx-100-iv-ketamine

Formulation based on prior patents by NRx founderAchieved pH neutral formulation of ketamine, potentially enabling both intrave...

 nrx-pharmaceuticals-announces-data-lock-of-phase-2b3-trial-of-nrx-101-in-suicidal-treatment-resistant-bipolar-depression-with-data-from-this-study-and-fda-comment-nrx-becomes-eligible-to-receive-the-balance-of-its-first-milestone-of-an-additional-4m-from-partners-alvogen-inc-and-lotus-pharmaceuticals-inc

Data transferred for independent statistical analysisTop-line data expected in April 2024RADNOR, Pa., April 8, 2024 /PRNewswire...

 nrx-pharmaceuticals-q4-eps-005-beats-007-estimate

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION